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The number of cases of nontuberculosis mycobacteria (NTM) is increasing, especially in developed countries. In our hospital-based survey of pulmonary NTM disease patients in Japan, the number of pulmonary *Mycobacterium abscessus* disease cases increased 5-fold relative to a survey conducted 7 years earlier ([@B1]). Moreover, the finding that the multidrug-resistant *M. abscessus* complex (MABC) is transmissible between patients with conditions such as cystic fibrosis provided a radical shift in thinking about MABC acquisition, which was previously thought to be environmental ([@B2][@B3][@B4]). Despite advances made in the genomics and documentation of clinical phenotypical differences among MABCs, discrepancies in conventional DNA-DNA hybridization (DDH) results led to debate about MABC taxonomic differentiation ([@B3], [@B5][@B6][@B9]).

Here, we report the complete genome sequence of *M. abscessus* subsp. *bolletii* BD^T^ (=CIP108541^T^). The strain was grown in Middlebrook 7H9 medium, and DNA was extracted using a standard phenol-chloroform method. The genome sequence was determined using PacBio reads (112,992 reads) obtained with the RS II system (Pacific Biosciences, Menlo Park, CA, USA) ([@B10][@B11][@B12]). The reads were *de novo* assembled with Canu version 1.5 ([@B13]), and the assembled genome was circularized by manually trimming the repeated sequences. Illumina 2 × 300-bp paired-end reads (100,578,382 reads) were obtained with the MiSeq system (Illumina, San Diego, CA, USA) and mapped to the assembly using the Burrows-Wheeler aligner ([@B14]) for sequence and assembly error correction with Pilon ([@B15]). The DDBJ Fast Annotation and Submission Tool (DFAST) (<https://dfast.nig.ac.jp/>) was used for annotation ([@B16]). Average nucleotide identity (ANI), genome-to-genome distance (GGD), and genomic signature-delta distance (GS-DD) were calculated by JSpeciesWS, Genome-to-Genome Distance Calculator 2.1 (<http://ggdc.dsmz.de/ggdc.php>), and δ\*-differences (<http://www.cmbl.uga.edu/software/delta-differences.html>), respectively ([@B17][@B18][@B19]).

The length of the *M. abscessus* subsp. *bolletii* BD^T^ genome is 5,080,450 bp (64.1% G+C content). Mycobacterium-related ANI was 96.95% to *M. abscessus* subsp. *abscessus* (complete genome of strain ATCC_19977^T^ \[[@B20]\]) and 96.73% to *M. abscessus* subsp. *massiliense* (complete genome of strain JCM_15300^T^ \[[@B7]\]). GGD-estimated DDH values between strains BD^T^ and ATCC_19977^T^, strains ATCC_19977^T^ and JCM_15300, and strains JCM_15300 and BD^T^ were 87.0%, 86.0%, and 88.1%, respectively. The GS-DD was 23 for these 3 comparisons. These values support the proposed taxonomic position of *M. abscessus* subsp. *bolletii* ([@B3]). The number of predicted protein-coding sequences in the genome (*n* = 4,976) is nearly equivalent to those of *M. abscessus* subsp. *abscessus* (*n* = 4,920) and *M. abscessus* subsp. *massiliense* (*n* = 4,857) ([@B7], [@B20]). The numbers of rRNA operons (*n* = 3) and tRNA genes (*n* = 49) are similar or equivalent to those of close relatives. Although a draft genome sequence for *Mycobacterium abscessus* subsp. *bolletii* BD^T^ was previously determined ([@B21]), the number of predicted genes differed significantly from that obtained here. We also identified a 97.1-kb prophage that was longer than that seen in a previous study (63 kb) ([@B21]). The complete genome sequence of *M. abscessus* subsp. *bolletii* BD^T^ represents essential data for future taxonomic and comparative genome studies.
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The chromosome sequence was deposited in DDBJ/ENA/GenBank under accession no. [AP018436](https://www.ncbi.nlm.nih.gov/nuccore/AP018436).
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